Abstract: Certain aspects of the present disclosure present a method for providing communication in a virtual world. The method generally includes receiving, via one or more microphones, voice data of a user corresponding to an avatar in the virtual world, selecting, from a plurality of devices associated with a plurality of other avatars in the virtual world, at least one device based, at least in part, on an intensity of the voice data of the user, and communicating the voice data to the selected at least one device.

Abstract: To update subscription related information using explicit notifications different solutions resulting to a notification updating information relating to a plurality of subscriptions per a network function are disclosed.

Abstract: A method to improve virtual desktop infrastructure (VDI) user experience includes providing a user access to a first virtual desktop executing a first set of applications and having a first virtual machine (VM) configuration, collecting VDI performance metrics associated with the first virtual desktop, detecting a problem from the VDI performance metrics, and changing a first remote display protocol configuration to address the problem. The method further includes collecting the user's feedback, training a model with the first VM configuration, the first set of applications, the user's feedback, and the first remote display protocol configuration, receiving a second VM configuration for a second virtual machine providing a second virtual desktop and a second set of applications on the second virtual desktop, using the model to generate a second remote display protocol configuration for the second virtual desktop, and configuring the second virtual desktop with the second remote display protocol configuration.

Abstract: A method to improve virtual desktop infrastructure (VDI) user experience includes providing a user access to a first virtual desktop executing a first set of applications and having a first virtual machine (VM) configuration, collecting VDI performance metrics associated with the first virtual desktop, detecting a problem from the VDI performance metrics, and changing a first remote display protocol configuration to address the problem. The method further includes collecting the user's feedback, training a model with the first VM configuration, the first set of applications, the user's feedback, and the first remote display protocol configuration, receiving a second VM configuration for a second virtual machine providing a second virtual desktop and a second set of applications on the second virtual desktop, using the model to generate a second remote display protocol configuration for the second virtual desktop, and configuring the second virtual desktop with the second remote display protocol configuration.

Abstract: Embodiments herein provide a method of managing grant of resources to a plurality of user equipments in a wireless communication network. The state corresponds to idle UEs, upload UEs and download UEs. The method includes identifying a state of the plurality of UEs. Further, the method includes managing grant of resources to one or more of the upload UEs and the download UEs, based on an operational condition of the UEs in the wireless communication network.

Abstract: Embodiments herein provide a method of managing grant of resources to a plurality of user equipments in a wireless communication network. The state corresponds to idle UEs, upload UEs and download UEs. The method includes identifying a state of the plurality of UEs. Further, the method includes managing grant of resources to one or more of the upload UEs and the download UEs, based on an operational condition of the UEs in the wireless communication network.

Abstract: A method of delivering a message containing medical information regarding a patient via a communications system is shown. The communications system is configured to receive the medical information from a first party and transmit medical information to a second party in a secured manner. The method includes receiving an audio message and a message recipient identity and storing the audio message. The method further includes transmitting the audio message for transcription and receiving a transcribed message data file from the transcription service. The method includes storing the transcribed message data file and analyzing the transcribed message data file to identify a patient identifier. The method includes formatting a notification that includes at least a portion of the transcribed message data file and the patient identifier. The method includes sending the notification to the message recipient.

Abstract: Disclosed are biologically active hetero pyrrole analogs such as imidazoles, thiazoles, oxazoles and pyrazoles capable of interacting with the CB1 and/or the CB2 cannabinoid receptors. One aspect discloses hetero pyrrole analogs acting as antagonists for the CB1 and/or the CB2 receptors. Another aspect discloses hetero pyrrole analogs having selectivity for the CB1 or CB2 cannabinoid receptor. Also disclosed are pharmaceutical preparations employing the disclosed analogs and methods of administering therapeutically effective amounts of the disclosed analogs to provide a physiological effect.

Abstract: Disclosed are biologically active hetero pyrrole analogs such as imidazoles, thiazoles, oxazoles and pyrazoles capable of interacting with the CB1 and/or the CB2 cannabinoid receptors. One aspect discloses hetero pyrrole analogs acting as antagonists for the CB1 and/or the CB2 receptors. Another aspect discloses hetero pyrrole analogs having selectivity for the CB1 or CB2 cannabinoid receptor. Also disclosed are pharmaceutical preparations employing the disclosed analogs and methods of administering therapeutically effective amounts of the disclosed analogs to provide a physiological effect.

Abstract: Disclosed are biologically active hetero pyrrole analogs such as imidazoles, thiazoles, oxazoles and pyrazoles capable of interacting with the CB1 and/or the CB2 cannabinoid receptors. One aspect discloses hetero pyrrole analogs acting as antagonists for the CB1 and/or the CB2 receptors. Another aspect discloses hetero pyrrole analogs having selectivity for the CB1 or CB2 cannabinoid receptor. Also disclosed are pharmaceutical preparations employing the disclosed analogs and methods of administering therapeutically effective amounts of the disclosed analogs to provide a physiological effect.

Abstract: Disclosed are biologically active hetero pyrrole analogs such as imidazoles, thiazoles, oxazoles and pyrazoles capable of interacting with the CB1 and/or the CB2 cannabinoid receptors. One aspect discloses hetero pyrrole analogs acting as antagonists for the CB1 and/or the CB2 receptors. Another aspect discloses hetero pyrrole analogs having selectivity for the CB1 or CB2 cannabinoid receptor. Also disclosed are pharmaceutical preparations employing the disclosed analogs and methods of administering therapeutically effective amounts of the disclosed analogs to provide a physiological effect.

Abstract: A turbo encoder includes multiple interleaved parallel concatenated recursive systematic convolutional encoders wherein each recursive systematic convolutional encoder is provided with an LUT that simultaneously provides the output bit pattern as well as the next state value corresponding to a defined set of multiple input bits and present state for operating the recursive systematic convolutional encoder. Thus, the approach works with LUTs, which do the job of both puncturing and multiplexing for four input bits at a time. The proposed approach may operate almost four times faster than the conventional approach, which can handle only one input bit at a time.

Abstract: The present invention relates to real-time adaptive control for best Integrated Circuit (IC) performance. The adaptive behavior is carried out on a local basis. The system is partitioned into different islands (30). Each island (30) is controlled and its working conditions are modified depending on some parameters. The remainder of the chip is controlled as well, depending on other parameters. This requires that each island (30) has a local controller (36) communicating with a global controller (42). The main control parameters are e.g. supply voltage, threshold voltage and clock frequency.

Abstract: A method is provided for synthesizing diaryl-substituted heterocyclic compounds, particularly 2,5-diaryl-substituted tetrahydrofurans and tetrahydrothiophenes. Methods for synthesizing starting materials and intermediates are provided as well. An important application of the invention is in the synthesis of CMI-392, (±) trans-2-[5-(N′-methyl-N′-hydroxyureidyl-methyl)-3-methoxy-4-p-chlorophenylthioethoxyphenyl]-5-(3,4,5-trimethoxyphenyl)-tetrahydrofuran, a highly effective agent in treating inflammatory and immune disorders. The invention also encompasses novel compounds useful as starting materials and intermediates in the synthetic processes disclosed.

Abstract: A method is provided for synthesizing diaryl-substituted heterocyclic compounds, particularly 2,5-diaryl-substituted tetrahydrofurans and tetrahydrothiophenes. Methods for synthesizing starting materials and intermediates are provided as well. An important application of the invention is in the synthesis of CMI-392, (±)trans-2-[5-N′-methyl-N′-hydroxyureidyl-methyl)3-methoxy-4-p-chlorophenylthioethoxyphenyl]-5-(3,4,5-trimethoxyphenyl)-tetrahydrofuran, a highly effective agent in treating inflammatory and immune disorders. The invention also encompasses novel compounds useful as starting materials and intermediates in the synthetic processes disclosed.

Abstract: A method is provided for synthesizing diaryl-substituted heterocyclic compounds, particularly 2,5-diaryl-substituted tetrahydrofurans and tetrahydrothiophenes. Methods for synthesizing starting materials and intermediates are provided as well. An important application of the invention is in the synthesis of CMI-392, (±) trans-2-[5-(N′-methyl-N′-hydroxyureidyl-methyl)-3-methoxy-4-p-chlorophenylthioethoxyphenyl]-5-(3,4,5-thrimethoxyphenyl)-tetrahydrofuran, a highly effective agent in treating inflammatory and immune disorders. The invention also encompasses novel compounds useful as starting materials and intermediates in the synthetic processes disclosed.